Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-23-000768
Filing Date
2023-12-13
Accepted
2023-12-13 16:40:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4103
  Complete submission text file 0001968582-23-000768.txt   5482
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38650 | Film No.: 231484503
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Gad Thomas (Reporting) CIK: 0001753224 (see all company filings)

Type: 144